MLH1 and colorectal carcinoma: Deficient MMR is also observed in 10% to 20% of patients with sporadic CRC, of which the majority of dMMR tumors are due to hypermethylation of MLH1 gene promoter, with MSH2 and MSH6 accounting for a smaller percentage [5].